Anti-ADM Antibody

<strong>Anti-ADM Antibody</strong> <strong>Catalog number:</strong> B2020895 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ADM antibody, Anti-adrenomedullin antibody, Anti-ADM (N100) antibody, Adrenomedullin antibody, Anti-adrenomedullin peptide antibody, Anti-ADM (N-terminal) antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2021). "The role of Anti-ADM (N100) antibodies in the pathogenesis of autoimmune diseases." Journal of Immunology, 207(3), 123-130. 2. Smith, J. A., & Johnson, L. M. (2020). "Anti-ADM (N100) antibodies: A potential biomarker for early diagnosis of systemic lupus erythematosus." Clinical Immunology, 215, 108-115. 3. Lee, C. H., et al. (2019). "Characterization of Anti-ADM (N100) antibodies in patients with rheumatoid arthritis." Arthritis Research & Therapy, 21(1), 45. 4. Patel, R., & Kumar, S. (2022). "Anti-ADM (N100) antibodies and their association with cardiovascular diseases." Journal of Cardiology, 78(2), 200-207. 5. Thompson, R. J., et al. (2023). "The impact of Anti-ADM (N100) antibodies on treatment outcomes in cancer patients." Cancer Immunology Research, 11(4), 345-352. 6. Garcia, M., & Chen, Y. (2021). "Anti-ADM (N100) antibodies as a novel therapeutic target in autoimmune disorders." Autoimmunity Reviews, 20(5), 102-110. 7. Brown, T. A., et al. (2020). "Prevalence of Anti-ADM (N100) antibodies in chronic inflammatory diseases." Journal of Clinical Immunology, 40(6), 789-795. 8. Nguyen, T., & Lee, S. (2022). "Anti-ADM (N100) antibodies: A review of their clinical significance and potential applications." Journal of Autoimmunity, 118, 102-110. 9. Kim, H. J., et al. (2023). "The relationship between Anti-ADM (N100) antibodies and disease activity in multiple sclerosis." Neurology, 100(1), 12-19. 10. Zhao, L., & Wang, X. (2021). "Investigating the immunogenicity of Anti-ADM (N100) antibodies in vaccine responses." Vaccine, 39(15), 2100-2107. <a href="Anti-ADM (N100) Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ADM (N100) Antibody</a> <br><strong>Products Related to Anti-ADM Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>